Voyager Therapeutics, Inc. (VYGR) Revenue 2016–2025
Voyager Therapeutics, Inc. (VYGR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$40.4MFY2025 · since FY2016: $14.2M → $40.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40.4M | -49.5% |
| FY2024 | $80.0M | -68.0% |
| FY2023 | $250.0M | +511.2% |
| FY2022 | $40.9M | +9.3% |
| FY2021 | $37.4M | -78.1% |
| FY2020 | $171.1M | +63.9% |
| FY2019 | $104.4M | +1270.1% |
| FY2018 | $7.6M | -24.8% |
| FY2017 | $10.1M | -28.7% |
| FY2016 | $14.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice